"Hindlimb Suspension" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Technique for limiting use, activity, or movement by immobilizing or restraining animal by suspending from hindlimbs or tails. This immobilization is used to simulate some effects of reduced gravity and study weightlessness physiology.
| Descriptor ID |
D019417
|
| MeSH Number(s) |
E05.472.760.370 E05.977.400 N06.230.150.440.950.400
|
| Concept/Terms |
Hindlimb Suspension- Hindlimb Suspension
- Suspension, Hindlimb
- Hindlimb Unloading
- Unloading, Hindlimb
- Unloadings, Hindlimb
- Hindlimb Elevation
- Elevation, Hindlimb
- Hindlimb Immobilization
- Immobilization, Hindlimb
Skeletal Unloading- Skeletal Unloading
- Skeletal Unloadings
- Unloading, Skeletal
- Unloadings, Skeletal
|
Below are MeSH descriptors whose meaning is more general than "Hindlimb Suspension".
Below are MeSH descriptors whose meaning is more specific than "Hindlimb Suspension".
This graph shows the total number of publications written about "Hindlimb Suspension" by people in this website by year, and whether "Hindlimb Suspension" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2005 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2008 | 0 | 1 | 1 |
| 2009 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hindlimb Suspension" by people in Profiles.
-
Ring RH, Schechter LE, Leonard SK, Dwyer JM, Platt BJ, Graf R, Grauer S, Pulicicchio C, Resnick L, Rahman Z, Sukoff Rizzo SJ, Luo B, Beyer CE, Logue SF, Marquis KL, Hughes ZA, Rosenzweig-Lipson S. Receptor and behavioral pharmacology of WAY-267464, a non-peptide oxytocin receptor agonist. Neuropharmacology. 2010 Jan; 58(1):69-77.
-
Rahman Z, Ring RH, Young K, Platt B, Lin Q, Schechter LE, Rosenzweig-Lipson S, Beyer CE. Inhibition of uptake 2 (or extraneuronal monoamine transporter) by normetanephrine potentiates the neurochemical effects of venlafaxine. Brain Res. 2008 Apr 08; 1203:68-78.
-
Cook MN, Dunning JP, Wiley RG, Chesler EJ, Johnson DK, Miller DR, Goldowitz D. Neurobehavioral mutants identified in an ENU-mutagenesis project. Mamm Genome. 2007 Aug; 18(8):559-72.
-
Lebsack TW, Kreulen C, Deever DB, Harris DT, Witten ML. Substance P effects on developing thymocytes in hindlimb unloaded rats. Aviat Space Environ Med. 2005 Jan; 76(1):11-8.